Skeletal growth factor involvement in the regulation of fracture healing process

In Vivo

Volumn 17, Issue 5, 2003, Pages 489-503

  Themistocleous, G S ^a,b   Kontou, S E ^b   Lembessis, P ^a   Katopodis, H A ^a   Kaseta, M A ^b   Themistocleous, M S ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Elpis Hospital   (Greece)

Author keywords

Bone cells; Fracture healing; Growth substances

Indexed keywords

BONE GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PAMIDRONIC ACID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT BONE MORPHOGENETIC PROTEIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 2; SOMATOMEDIN; SOMATOMEDIN A; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOCRINE EFFECT; BONE REMODELING; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DEVELOPMENTAL STAGE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; ENDOCRINE FUNCTION; FRACTURE; FRACTURE HEALING; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; OSSIFICATION; OSTEOPENIA; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION REGULATION;

EID: 0142198851     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (162)

1. Brighton CT and Hunt T: Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am 73: 832-847, 1991.
2. Bolander ME: Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200: 165-170, 1998.
3. Einhorn TA: The cell and molecular biology of fracture healing. Clin Orthop 355S: S7-S21, 1998.
4. Einhom TA, Majeska RJ, Rush EB, Levine PM and Horowitz MC: The expression of cytokine activity by fracture callus. J Bone Miner Res 10: 1272-1281, 1995.
5. Trippel SB: Growth factors as therapeutic agents. Instr Course Lect 46: 473-476, 1997.
6. Trippel SB and Rosenfeld RG: Growth factor treatment of disorders of skeletal growth. Instr Course Lect 46: 477-482, 1997.
7. Andrew JG, Hoyland J, Freemont AJ and Marsh D: Insulin-like growth factor gene expression in human fracture callus. Calcif Tissue Int 53: 97-102, 1993.
8. Bak B, Jorgensen PH and Andreassen TT: Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 61: 54-57, 1990.
9. Rajaram S, Baylink DJ and Mohan S: Insulin-like growth factor binding proteins in serum and other biological fluids. Regulation and functions. Endocr Rev 18: 801-831, 1997.
10. Rechler MM: Insulin-like growth factor binding proteins. Vitam Horm 47: 111-114, 1993.
11. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RC and Rutter WJ: Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329: 301, 1987.
12. Rosenfeld RG and Hintz RL: Somatomedin receptors: Structure, function and regulation. In: Conn PM (ed.): The Receptors. New York, Academic Press 281: 1986.
13. Rechler M and Nisslev SP: The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47: 45, 1985.
14. Ullrich A, Gray A, Tam AW et al: Insulin-like growth factor 1 receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503-2512, 1986.
15. LeRoith D, Werner H, Beitner-Johnson D et al: Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr Rev 16: 143-163, 1995.
16. Murphy LJ, Bell GI, Duckworth ML et al: Identification, characterization, and regulation of complementary deoxyribonucleic acid which evokes insulin-like growth factor 1. Endocrinology 121: 684, 1987.
17. Hepler JE, Van Wyk JJ and Lund PK: Different half lives of insulin-like growth factor-I mRNA that differ in length of 3′ untranslated sequence. Endocrinology 127: 155, 1990.
18. Martinez DA, Zuscik MJ, Ishibe M et al: Identification of functional insulin-like growth factor-II/mannose-6-phosphate receptors in isolated bone cells. J Cell Biochem 59: 246-257, 1995.
19. Mohan S, Wergedal JE and Taylor AK: IGF-I and II are produced by human osteoblast-like cells in culture. FASEB 2: 842, 1988.
20. Kim HS, Nagalla SR, Oh Y et al: Synthesis and characterization of connective tissue growth factor (CTGF) as insulin-like growth factor-binding protein (IGFBP). Proceedings of the 79th Annual Meeting of the Endocrine Society. 352, 1997.
21. Pelf JM and Flick-Smith HC: Bioactivity of IGF- VIGFBP-3/Anti-IGFBP-3 antibody complexes. Proceedings of the 79th Annual Meeting of the Endocrine Society. 347, 1997.
22. McCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C and Clemmons DR: Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 129(2): 939-949, 1991.
23. Mohan S, Bautista CM, Wergcdal J and Baylink DJ: Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc Natl Acad Sci USA 86: 8338-8342, 1989.
24. Canalis E, Pash J and Varghese S: Skeletal growth factors. Crit Rev Eukaryotic Gene Expression 3: 155-166, 1993.
25. Dequeker J, Mohan S, Finkelman RD, Aerssens J and Baylink DJ: Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 36(12): 1702-1708, 1993.
26. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K and Baylink DJ: Studies on the mechanism by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270: 20424-20431, 1995.
27. Mundy GR: Factors which stimulate bone growth in vivo. Growth Regul 3: 124-128, 1993.
28. Rosen CJ, Donahue LR and Hunter S: Insulin-like growth factors and bone, the osteoporosis connection. Proc Soc Exp Biol Med 206: 83-102, 1994.
29. Amarnani S, Merriman HL, Linkhart TA, Baylink DJ and Mohan S: Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Min Res 8(2): 157-165, 1993.
30. Mohan S and Baylink DJ: Bone growth factors. Clin Orth Rel Res 263: 30-48, 1991.
31. Edwall D, Prisell PT, Levinovitz A, Jennische E and Norstedt G: Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: Influence of indomethacin. J Bone Min Res 7: 207-213, 1992.
32. Prisell PT, Edwall D, Lindblad JB, Levinovitz A and Norstedt G: Expression of insulin-like growth factors during bone induction in rat. Calcif Tiss Int 53: 201-205, 1993.
33. Sandberg MM, Aro HT and Vuorio EI: Gene expression during bone repair. Clin Orth Rel Res 289: 292-312, 1993.
34. Chevalley T, Strong DD, Mohan S, Baylink D and Linkhart TA: Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation. Eur J Endocrinol 134(5): 591-601, 1996.
35. Ernst M and Rodan GA: Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127: 807-814, 1990.
36. Ebeling PR, Jones JD, O'Fallon WM, Janes CH and Riggs BL: Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77: 1384-1387, 1993.
37. Baxter RC: Insulin-like growth factor (IGF) binding proteins: The role of serum IGFBPs in regulating IGF availability. Acta Paed Scand [Suppl] 372: 107-114, 1991.
38. Linkhart TA, Mohan S and Baylink DJ: Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 19(1Suppl): 1S-12S, 1996.
39. Spencer EM, Liu CC, Si EC and Howard GA: In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12(1): 21-26, 1991.
40. Ammann P, Rizzoli R, Muller K, Slosman D and Bonjour JP: IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol 265(5 Pt 1): E770-776, 1993.
41. Mueller K, Cortesi R, Modrowski D and Marie PJ: Stimulation of trabecular bone formation by insulin-like growth factor I in adult variectomized rats. Am J Physiol 267(1 Pt 1): E1-6, 1994.
42. Machwate M, Zerath E, Holy X, Hott M, Godet D, Lomri A and Marie PJ: Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats. J Clin Invest 96(3): 1245-1253, 1995.
43. Carpenter JE, Hipp JA, Gerhart TN, Rudman CG, Hayes WC and Trippel SB: Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg Am 74: 359-367, 1992.
44. Thaller SR, Dart A and Tesluk H: The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 31: 429-433, 1993.
45. Heldin CH and Westermark B: PDGF-like growth factors in autocrine stimulation of growth. J Cell Physiol Suppl 5: 31-34, 1987.
46. Westermark B and Heldin CH: Platelet-derived growth factor. Acta Oncol 32: 101-105, 1993.
47. Majack R, Majesky MW and Goodman LV: Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol 111(1): 239-247, 1990.
48. Collins T, Pober J, Gimbrone M et al.: Cultured human 21 endothelial cells express platelet-derived growth factor A chain. Am J Pathol 127: 7-12, 1987.
49. Canalis E, Varghese S, McCarthy TL and Centrella M: Role of platelet-derived growth factor in bone cell function. Growth Regul 2: 151-155, 1992.
50. Rydziel S, Shaikh S and Canalis E: Platelet-derived growth factors AA and BB enhance the synthesis of platelet-derived growth factor AA in bone cell cultures. Endocrinology 134: 2541-2546, 1994.
51. Betsholtz C, Johnsson A, Heldin C-H et al: cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320(6064): 695-699, 1986.
52. Doolittle F, Hunkapiller M.W, Hood L et al: Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221(4607): 275-7, 1983.
53. Graves T, Owen AJ, Barth RK et al.: Detection of csis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells. Science 226: 972-974, 1984.
54. Heldin H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C and Westermark B: A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511-514, 1986.
55. Seifert RA, Hart CE, Phillips PE et al.: Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264: 8771-8778, 1989.
56. Yarden Y, Escobedo JA, Kuang WJ et al.: Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226-232, 1986.
57. Gronwald R, Grant FJ, Haldeman BA et al.: Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. J Biomol NMR 12(3): 395-405, 1998.
58. Heldin CH, Ernlund A, Rorsman C and Ronnstrand L: Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J Biol Chem 264: 8905-8912, 1989.
59. Claesson-Welsh L: Platelet-derived growth factor recep- 43 for signals. J Biol Chem 269: 32023-32026, 1994.
60. Eriksson A, Nister M, Levjen P et al.: Induction of platelet-derived growth factor a- and, 8-receptor mRNA and protein by platelet-derived growth factor BB. J Biol Chem 266 (31): 21138-21144, 1991.
61. Andrew JG, Hoyland J, Freemont AJ and Marsh D: Platelet-derived growth factor expression in normally healing human fractures. Bone 16: 455-460, 1995.
62. Shimokado K, Raines EW, Madtes DK, Barren T, Benditt EP and Ross R: A significant part of macrophage derived growth factor consists of at least two forms of PDGF. Cell 43: 277-286, 1985.
63. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ: Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 5: 203-208, 1994.
64. Marden LJ, Fan RS, Pierce GF, Reddi AH and Hollinger JO: Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. J Clin Invest 92(6): 2897-905, 1993.
65. Lind M: Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl 283: 2-37, 1998.
66. Wang JS: Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand Suppl 269: 1-33, 1996.
67. Friesel RE and Maciag T: Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9: 919-25, 1995.
68. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE and Klagsburn M: Growth factors in bone matrix: Isolation of multiple types by affinity chromatography on heparin-sepharose. J Biol Chem 261: 12665-12674, 1986.
69. Baird A and Walicke PA: Fibroblast growth factors. Br Med Bull 45: 438-452, 1989.
70. Vlodavsky I, Fuks Z, Ishai-Michaeli R et al.: Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis. J Cell Biochem 45: 167-176, 1991.
71. Burgess WH and Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58: 575-606, 1989.
72. Baird A and Klagsbrun M: The fibroblast growth factor family. Cancer Cells 3: 239-243, 1991.
73. Baird A: Editorial: Fibroblast growth factors: What's in a name? Endocrinology 132: 487-488, 1993.
74. Globus RK, Plouet J and Gospodarowicz D: Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124: 1539-1547, 1989.
75. Hurley M, Abreu C, Gronowicz G, Kawaguchi H and Lorenzo J: Expression and regulation of basic fibroblast growth factor-2 in bone. Endocrinology 140(1): 434-444, 1999.
76. Ornitz M and Leder P: Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 267: 16305-16311, 1992.
77. Werner S, Duan DS, De Vries C, Peters KG, Johnson DE and Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12(1): 82-88, 1992.
78. Wang J, Gao G and Goldfarb M: Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14: 181-188, 1994.
79. Spivak-Kroizman T, Lemmon MA, Dikic I et al: Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79(6): 1015-24, 1994.
80. Jingushi S, Heydemann A, Kana SK, Macey LR and Bolander N: Acidic fibroblast growth factor (aFGF) injection stuns late cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J Orthop Res 8: 364-371, 1990.
81. Canalis E, McCarthy TL and Centrella M: Growth factors and cytokines in bone cell metabolism. Ann Rev Med 42: 17-24, 1991.
82. Johnson EE, Urist MR and Finerman GA: Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop 230: 257-65, 1988.
83. Kato T, Kawaguchi H, Hanada K et al.: Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 16: 654-59, 1998.
84. Nakamura T, Hara Y, Tagawa M, Tamura M, Yuge T, Fukud H and Nigi H: Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fractures. J Bone Miner Res 13: 942-949, 1998.
85. Kawaguchi H, Kurokawa T, Hanada K et al.: Stimulation of fracture repair by recombinant human basic fibroblast growth factor in norms and streptozotocin-diabetic rats. Endocrinology 135: 774-781, 1994.
86. Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spin RC and Poser JW: A novel formulation of FGF-2 in a hyaluronan gel accelerates fracture healing in non-human primates. J Orthop Res 17: 607-614, 1999.
87. Bland YS, Critchlow MA and Ashhurts DE: Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. Acts Orthop Scand 66: 543-548, 1995.
88. Radomsky ML, Thompson AY, Spiro RC and Poser JW: Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop 355(Supp): S283-293, 1998.
89. Nakamura K, Kawaguchi H, Aoyama I et al.: Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 15: 307-313, 1997.
90. Rosier RN, O'Keefe RJ and Hicks DG: The potential role of transforming growth factor beta in fracture healing. Clin Orthop 355 Suppl: S294-300, 1998.
91. Massague J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-54, 2000.
92. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM and Massague J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-3, 1996.
93. Shull M, Ormsby I, Kier AB et al: Targeted disruption of the mouse transforming growth factor-beta gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
94. Bonewald LF and Dallas SL: Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55: 350-357, 1994.
95. Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR and Bonewald LF: Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J Biol Chem 269: 6815-6821, 1994.
96. Miyazono H, Ichijo H and Heldin C: Transforming growth factor-β: Latent forms, binding proteins and receptors. Growth Factors 8: 11-22, 1993.
97. Derynck R, Jarrett JA, Chen EY and Goeddel DV: The murine transforming growth factor-β precursor. J Biol Chem 261: 4377-4379, 1986.
98. Wakefield M, Smith DM, Flanders KC and Sporn MB: Latent transforming growth factor-β from human platelets. J Biol Chem 263 (16): 7646-54, 1988.
99. Miyazono U, Hellman C, Wernstedt C and Heldin CH: Latent high molecular weight complex of transforming growth factor beta. J Biol Chem 263: 6407-6415, 1988.
100. Miyazono A, Olofsson P, Colosetti and Heldin CH: A role of the latent TGF-beta-1-binding protein in the assembly and secretion of TGF-beta-1. EMBO J 10: 1091-1101, 1991.
101. Kingsley DM: The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146, 1994.
102. Andrew JG, Hoyland J, Andrew SM et al: Demonstration of TGF-beta 1 mRNA by in situ hybridization in normal human fracture healing. Calcif Tissue Int 52: 74-78, 1993.
103. Massague J, Attisano L and Wrana JL: The TGF-beta family and its composite receptors. Trends Cell Biol 4: 172-178, 1994.
104. Massague J: The transforming growth factor-beta family. Ann Rev Cell Biol 6: 597-641, 1990.
105. Massague J: Receptors for the TGF-beta family. Cell 69: 1067-1070, 1992.
106. Derynck R, Zhang Y and Feng XH: Smads: Transcriptional activators of TGF-beta responses. Cell 95: 737-740, 1998.
107. Robey PG, Young MF, Flanders KC et al: Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105: 457-63, 1987.
108. Bourque WT, Gross M and Hall BK: Expression of four growth factors during fracture repair. Int J Dev Biol 37: 573-79, 1993.
109. Joyce ME, Jinguishi S and Bolander ME: Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North Am 21: 199-209, 1990.
110. Noda M and Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991-994, 1989.
111. Lind M, Schumacker B, Soballe K, Keller J, Melsen F and Bunger C: Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64: 553-6, 1993.
112. Nielsen HM, Andreassen TT, Ledet T and Oxlund H: Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 65: 37-41, 1994.
113. Critchlow MA, Bland YS and Ashhurst DE: The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 16: 521-7, 1995.
114. Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM and Galante JO: Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 77: 1135-47, 1995.
115. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillet NA and Amento EP: TGF-beta induces bone closure of skull defects. J Bone Miner Res 6: 1257-1265, 1991.
116. Ripamonti U, Bosch C, Van Den Heever B, Duneas N, Melsen B and Ebner R: Limited chondro-osteogenesis by recombinant human transforming growth factor-beta 1 in calvarial defects of adult baboons (Papio ursinus). J Bone Miner Res 11(7): 938-45, 1996.
117. Ongpipattanakul B, Nguyen T, Zioncheck TF, Wong R, Osaka G, DeGuzman L, Lee WP and Beck LS: Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. J Biomed Mater Res 36(3): 295-305, 1997.
118. Urist MR: Bone: Formation by autoinduction. Science 150: 893-899, 1966.
119. Reddi AH and Cunningham NS: Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8 Suppl 2: S499-502, 1993.
120. Urist MR: The search for and discovery of bone morphogenetic protein (BMP). In: Urist MR, O'Conner BT, Burwell RG, eds. Bone Grafts, Derivatives and Substitutes: 315-362, 1994.
121. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Rep Dev 32: 160-167, 1992.
122. Reddi AH: Initiation of fracture repair by bone morfogenetic proteins. Clin Orthop 355[Suppl]: S66-S72, 1998.
123. Hogan BL: Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 10(13): 1580-94, 1996.
124. Bostrom MP, Lane JM, Berberian WS et al.: Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13: 357-367, 1995.
125. Finkelman RD, Bell NH, Strong DD, Demers LM and Baylink DJ: Ovariectomy selectively reduces the concentrations of transforming growth factor beta in rat bone: Implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 89: 12190-12193, 1992.
126. Nakase T, Nomura S, Yoshikawa H et al.: Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9: 651-659, 1994.
127. Heldin CH, Miyazono K and Dijke PT: TGF-R signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
128. Brunet LJ, McMahon JA, McMahon AP and Harland RM: Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455-1457, 1998.
129. Gazzero E, Gnagji V and Canalis E: Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102: 2106-2114, 1998.
130. Ishidou Y, Kitajima I, Obama H et al.: Enhanced expression of type I receptors for bone morphegenetic proteins during bone formation. J Bone Miner Res 10: 1651-1659, 1995.
131. Rosen V and Wozney J: Bone morfogenetic proteins and the adult skeleton. In: Canalis E, eds. Skeletal Growth Factors. Philadelphia: Lippincott Williams 299-310, 2000.
132. Barnes GL, Kostenuik PJ, Gerstenfeld LC and Einhorn TA: Growth factor regulation of fracture repair. Bone Miner Res 14(11): 1805-15, 1999.
133. Bostrom MP: Expression of bone morphogenetic proteins in fracture healing. Clin Orthop 355 (Supp): S116-S123, 1998.
134. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM and Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528-34, 1988.
135. Wang YJ, Lin FH, Sun JS, Huang YC, Chueh SC and Hsu FY: Collagen-hydroxyapatite microspheres as carriers for bone morphogenic protein-4. Artif Organs 27(2): 162-8, 2003.
136. Konishi S, Nakamura H, Seki M, Nagayama R and Yamano Y: Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion. J Spinal Disord Tech 15(3): 237-44, 2002.
137. Kandziora F, Bail H, Schmidmaier G et al.: Bone morphogenetic protein-2 application by a poly (D,L-lactide)-coated interbody cage: In vivo results of a new carrier for growth factors. J Neurosurg 97(1 Suppl): 40-8, 2002.
138. Bessho K, Carnes DL, Cavin R and Ong JL: Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 61(1): 61-5, 2002.
139. Partridge K, Yang X, Clarke NM et al; Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 292(1): 144-52, 2002.
140. Burkus JK, Gornet MF, Dickman CA and Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15(5): 337-49, 2002.
141. Murakami N, Saito N, Horiuchi H, Okada T, Nozaki K and Takaoka K: Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer. J Biomed Mater Res 62(2): 169-74, 2002.
142. Pajamaki KJ, Andersson OH, Lindholm TS, Karlsson KH, Yli-Urpo A and Happonen RP: Effect of bovine bone morphogenetic protein and bioactive glass on demineralized bone matrix grafts in the rat muscular pouch. Ann Chir Gynaecol Suppl 207: 155-61, 1993.
143. Pajamaki KJ, Andersson OH, Lindholm TS, Karlsson KH and Yli-Urpo A: Induction of new bone by allogeneic demineralized bone matrix combined to bioactive glass composite in the rat. Ann Chir Gynaecol Suppl 207: 137-43, 1993.
144. Bessho K and Iizuka T: Changes in bone inducing activity of bone morphogenetic protein with aging. Ann Chir Gynaecol Suppl 207: 49-53, 1993.
145. Johnson EE and Urist MR: Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. Clin Orthop 236: 249-257, 1988.
146. Johnson EE, Urist MR and Finerman GAM: Resistant nonunions and partial or complete segmental defects of long bones. Clin Orthop 277: 229-237, 1992.
147. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA and Wozney JM: Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13(3-4): 291-300, 1996.
148. Heckman JD, Boyan BD, Aufdemorte TB and Abbott JT: The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am 730: 750-764, 1991.
149. Cook SD, Baffes GC, Wolfe MW, Sampath TK and Rueger DC: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301: 302-312, 1994.
150. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC and Whitecloud TS: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76: 827-838, 1994.
151. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM and Wang EA: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 74: 659-671, 1992.
152. Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp JA, Schelling SH and Wang EA: Healing segmental femoral defects in sheep using recombinant human bone morfogenetic protein. Clin Orthop 293: 317-326, 1993.
153. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J and Schildhauer T: The use of bone morphogenetic protein-2 in the rabbit ulnar non-union model. Clin Orthop 327: 272-282, 1996.
154. Stevenson S, Cunningham N, Toth J, Davy D and Reddi AH: The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. J Bone Joint Surg Am 76: 1676-1687, 1994.
155. Ripamonti U, Ma S, Cunningham NS, Yeates L and Reddie AH: Initiation of bone regeneration in adult baboons by osteogenin, a bone morphogenetic protein. Matrix 12: 369-380, 1992.
156. Cook SD, Wolfe MW, Salkeld SL and Rueger DC: Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77: 734-50, 1995.
157. Sciadini MF and Johnson KD: Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18: 289-302, 2000.
158. Bostrom MP and Camacho NP: Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 355 Suppl: 274-82, 1998.
159. Schimandle JH, Boden SD and Hutton WC: Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20: 1326-37, 1995.
160. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegan EN, Liu D, Seeger LL and Dawson EG: Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20: 2669-82, 1995.
161. Muschler GF, Hyodo A, Manning T, Kambic H and Easley K: Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 308: 229-40, 1994.
162. Boden SD, Martin GJ Jr, Horton WC, Truss TL and Sandu HS: Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11: 95-101, 1998.